Back to Journals » Biologics: Targets and Therapy » Volume 4 » default

Biologics: Targets and Therapy


Archived Journals

Archive: Volume 4, 2010

Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?

Jürgen Frevert, Dirk Dressler

Biologics: Targets and Therapy 2010, 4:325-332

Published Date: 9 December 2010

Gaucher disease: clinical profile and therapeutic developments

Timothy M Cox

Biologics: Targets and Therapy 2010, 4:299-313

Published Date: 6 December 2010

The emerging role of nimotuzumab in the treatment of non-small cell lung cancer

William Boland, Gwyn Bebb

Biologics: Targets and Therapy 2010, 4:289-298

Published Date: 9 November 2010

Proteasome inhibition and its therapeutic potential in multiple myeloma

Ajai Chari, Amitabha Mazumder, Sundar Jagannath

Biologics: Targets and Therapy 2010, 4:273-287

Published Date: 28 September 2010

New and emerging treatment approaches to lupus

Marion Haubitz

Biologics: Targets and Therapy 2010, 4:263-271

Published Date: 6 September 2010

Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer

Jaclyn Flanigan, Hari Deshpande, Scott Gettinger

Biologics: Targets and Therapy 2010, 4:237-243

Published Date: 26 August 2010

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer

Mohamedtaki A Tejani, Roger B Cohen, Ranee Mehra

Biologics: Targets and Therapy 2010, 4:173-185

Published Date: 28 June 2010

Decreasing glioma recurrence through adjuvant cancer stem cell inhibition

Josh Neman, Rahul Jandial

Biologics: Targets and Therapy 2010, 4:157-162

Published Date: 22 June 2010

Managing idiopathic short stature: role of somatropin (rDNA origin) for injection

J Paul Frindik, Stephen F Kemp

Biologics: Targets and Therapy 2010, 4:147-155

Published Date: 9 June 2010

Potential role of ustekinumab in the treatment of chronic plaque psoriasis

Santo Raffaele Mercuri, Luigi Naldi

Biologics: Targets and Therapy 2010, 4:119-129

Published Date: 10 May 2010

Use of clofarabine for acute childhood leukemia

A Pession, R Masetti, K Kleinschmidt, et al

Biologics: Targets and Therapy 2010, 4:111-118

Published Date: 24 June 2010

Palliative treatment of malignant ascites: profile of catumaxomab

Lila Ammouri, Eric E Prommer

Biologics: Targets and Therapy 2010, 4:103-110

Published Date: 14 May 2010

Management of patients with advanced non-small cell lung cancer: role of gefitinib

Vamsidhar Velcheti, Daniel Morgensztern, Ramaswamy Govindan

Biologics: Targets and Therapy 2010, 4:83-90

Published Date: 19 April 2010

Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model

Brent Sorenson, Kaysie Banton, Lance Augustin, et al

Biologics: Targets and Therapy 2010, 4:61-73

Published Date: 16 March 2010

A combined phase I and II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis

Stephen P Myers, Joan O’Connor, J Helen Fitton, et al.

Biologics: Targets and Therapy 2010, 4:33-44

Published Date: 12 February 2010

Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib

Richard Quek, Suzanne George

Biologics: Targets and Therapy 2010, 4:19-31

Published Date: 3 February 2010

Recombinant follitropin alfa/lutropin alfa in fertility treatment

Ahmed Gibreel, Siladitya Bhattacharya

Biologics: Targets and Therapy 2010, 4:5-17

Published Date: 22 December 2009

Safety of etanercept in elderly subjects with rheumatoid arthritis

Alfredomaria Lurati, Mariagrazia Marrazza, Katia Angela, et al

Biologics: Targets and Therapy 2010, 4:1-4

Published Date: 22 December 2009